Bioqual Statistics
Total Valuation
Bioqual has a market cap or net worth of 27.73 million. The enterprise value is 43.18 million.
| Market Cap | 27.73M |
| Enterprise Value | 43.18M |
Important Dates
The next estimated earnings date is Friday, January 22, 2027.
| Earnings Date | Jan 22, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioqual has 894,416 shares outstanding.
| Current Share Class | 894,416 |
| Shares Outstanding | 894,416 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.76% |
| Owned by Institutions (%) | n/a |
| Float | 205,671 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.07 |
| EV / EBITDA | 19.28 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.17, with a Debt / Equity ratio of 1.00.
| Current Ratio | 4.17 |
| Quick Ratio | 4.09 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 14.25 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.01% and return on invested capital (ROIC) is -9.84%.
| Return on Equity (ROE) | -13.01% |
| Return on Assets (ROA) | -4.86% |
| Return on Invested Capital (ROIC) | -9.84% |
| Return on Capital Employed (ROCE) | -7.80% |
| Weighted Average Cost of Capital (WACC) | 1.99% |
| Revenue Per Employee | 356,111 |
| Profits Per Employee | -39,066 |
| Employee Count | 113 |
| Asset Turnover | 0.66 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bioqual has paid 359,195 in taxes.
| Income Tax | 359,195 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.50% in the last 52 weeks. The beta is 0.01, so Bioqual's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -22.50% |
| 50-Day Moving Average | 51.34 |
| 200-Day Moving Average | 72.63 |
| Relative Strength Index (RSI) | 18.16 |
| Average Volume (20 Days) | 682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Bioqual had revenue of 40.24 million and -4.41 million in losses. Loss per share was -4.94.
| Revenue | 40.24M |
| Gross Profit | 5.97M |
| Operating Income | -4.75M |
| Pretax Income | -4.06M |
| Net Income | -4.41M |
| EBITDA | -2.65M |
| EBIT | -4.75M |
| Loss Per Share | -4.94 |
Balance Sheet
The company has 16.47 million in cash and 31.92 million in debt, with a net cash position of -15.45 million or -17.27 per share.
| Cash & Cash Equivalents | 16.47M |
| Total Debt | 31.92M |
| Net Cash | -15.45M |
| Net Cash Per Share | -17.27 |
| Equity (Book Value) | 31.95M |
| Book Value Per Share | 35.72 |
| Working Capital | 20.56M |
Cash Flow
In the last 12 months, operating cash flow was -165,451 and capital expenditures -485,235, giving a free cash flow of -650,686.
| Operating Cash Flow | -165,451 |
| Capital Expenditures | -485,235 |
| Depreciation & Amortization | 2.10M |
| Net Borrowing | n/a |
| Free Cash Flow | -650,686 |
| FCF Per Share | -0.73 |
Margins
Gross margin is 14.83%, with operating and profit margins of -11.80% and -10.97%.
| Gross Margin | 14.83% |
| Operating Margin | -11.80% |
| Pretax Margin | -10.08% |
| Profit Margin | -10.97% |
| EBITDA Margin | -6.58% |
| EBIT Margin | -11.80% |
| FCF Margin | n/a |
Dividends & Yields
Bioqual does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.93% |
| FCF Yield | -2.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 28, 1997. It was a reverse split with a ratio of 0.16666.
| Last Split Date | Oct 28, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.16666 |
Scores
Bioqual has an Altman Z-Score of 1.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.81 |
| Piotroski F-Score | 1 |